Riproximin mediated cytotoxicity and expression modifications in lung cancer cells. Cancer Research and Medicine, [S. l.], v. 1, n. 2, p. 64–69, 2025. DOI: 10.63626/3pe8e164. Disponível em: https://biologycircle.com/index.php/crm/article/view/25. Acesso em: 13 jun. 2026.